BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37959715)

  • 1. The Use of Cyclodextrin Inclusion Complexes to Increase the Solubility and Pharmacokinetic Profile of Albendazole.
    Ding Y; Zhang Z; Ding C; Xu S; Xu Z
    Molecules; 2023 Oct; 28(21):. PubMed ID: 37959715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
    Pacheco PA; Rodrigues LNC; Ferreira JFS; Gomes ACP; Veríssimo CJ; Louvandini H; Costa RLD; Katiki LM
    Parasitol Res; 2018 Mar; 117(3):705-712. PubMed ID: 29327323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of albendazole beta-cyclodextrin complexes.
    Castillo JA; Palomo-Canales J; Garcia JJ; Lastres JL; Bolas F; Torrado JJ
    Drug Dev Ind Pharm; 1999 Dec; 25(12):1241-8. PubMed ID: 10612019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubility and Pharmacokinetic Profile Improvement of Griseofulvin through Supercritical Carbon Dioxide-Assisted Complexation with HP-
    Ding Y; Cui W; Zhang Z; Ma Y; Ding C; Lin Y; Xu Z
    Molecules; 2023 Oct; 28(21):. PubMed ID: 37959779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexation of albendazole with hydroxypropyl-β-cyclodextrin significantly improves its pharmacokinetic profile, cell cytotoxicity and antitumor efficacy in nude mice.
    Ehteda A; Galettis P; Chu SW; Pillai K; Morris DL
    Anticancer Res; 2012 Sep; 32(9):3659-66. PubMed ID: 22993303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin.
    Evrard B; Chiap P; DeTullio P; Ghalmi F; Piel G; Van Hees T; Crommen J; Losson B; Delattre L
    J Control Release; 2002 Dec; 85(1-3):45-50. PubMed ID: 12480310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of a new cyclodextrin derivative with improved properties to design oral dosage forms.
    García A; Priotti J; Codina AV; Vasconi MD; Quiroga AD; Hinrichsen LI; Leonardi D; Lamas MC
    Drug Deliv Transl Res; 2019 Feb; 9(1):273-283. PubMed ID: 30264285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving bioavailability and anthelmintic activity of albendazole by preparing albendazole-cyclodextrin complexes.
    García-Rodriguez JJ; Torrado J; Bolás F
    Parasite; 2001 Jun; 8(2 Suppl):S188-90. PubMed ID: 11484352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of Albendazole, Albendazole Sulfoxide, and Albendazole Sulfone Determined from Plasma, Blood, Dried-Blood Spots, and Mitra Samples of Hookworm-Infected Adolescents.
    Schulz JD; Neodo A; Coulibaly JT; Keiser J
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Solubility of Albendazole in Cyclodextrin Inclusion Complex: A Molecular Modeling Approach and Physicochemical Evaluation.
    de Melo CG; da Costa LAG; Rabello MM; de Albuquerque Wanderley Sales V; Ferreira AS; da Silva PCD; Nishimura RHV; da Silva RMF; de Araújo Rolim L; Neto PJR
    Curr Drug Deliv; 2022; 19(1):86-92. PubMed ID: 34126897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complexation and solubility behavior of albendazole with some cyclodextrins.
    Díaz D; Bernad Bernad MJ; Gracia Mora J; Escobar Llanos CM
    Pharm Dev Technol; 1998 Aug; 3(3):395-403. PubMed ID: 9742560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the complexation of albendazole with cyclodextrins for the design of new antiparasitic formulations.
    Pradines B; Gallard JF; Iorga BI; Gueutin C; Loiseau PM; Ponchel G; Bouchemal K
    Carbohydr Res; 2014 Oct; 398():50-5. PubMed ID: 25240182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution.
    Ceballos L; Moreno L; Torrado JJ; Lanusse C; Alvarez L
    BMC Vet Res; 2012 May; 8():71. PubMed ID: 22640491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of solubility and pharmacokinetic profile of hepatoprotector icariin through complexation with HP-
    Ding Y; Yu B; Zhou S; Ding C; Zhang Z; Xu S; Xu Z
    Front Pharmacol; 2023; 14():1138686. PubMed ID: 37033648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of bioavailability and anthelmintic efficacy of albendazole by solid dispersion and cyclodextrin complexation techniques.
    Kalaiselvan R; Mohanta GP; Madhusudan S; Manna PK; Manavalan R
    Pharmazie; 2007 Aug; 62(8):604-7. PubMed ID: 17867556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of pioglitazone cyclodextrin inclusion complexes.
    Pandit V; Gorantla R; Devi K; Pai R; Sarasija S
    J Young Pharm; 2011 Oct; 3(4):267-74. PubMed ID: 22224032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albendazole Microcrystal Formulations Based on Chitosan and Cellulose Derivatives: Physicochemical Characterization and In Vitro Parasiticidal Activity in Trichinella spiralis Adult Worms.
    Priotti J; Codina AV; Leonardi D; Vasconi MD; Hinrichsen LI; Lamas MC
    AAPS PharmSciTech; 2017 May; 18(4):947-956. PubMed ID: 27882479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising applications in drug delivery systems of a novel β-cyclodextrin derivative obtained by green synthesis.
    García A; Leonardi D; Lamas MC
    Bioorg Med Chem Lett; 2016 Jan; 26(2):602-608. PubMed ID: 26642766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cyclodextrin complexation on the aqueous solubility and solubility/dose ratio of praziquantel.
    Maragos S; Archontaki H; Macheras P; Valsami G
    AAPS PharmSciTech; 2009; 10(4):1444-51. PubMed ID: 19949903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: the influence of the dose-regime.
    López-García ML; Torrado S; Torrado S; Martínez AR; Bolás F
    Vet Parasitol; 1998 Feb; 75(2-3):209-19. PubMed ID: 9637222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.